Risk of death in cystic fibrosis patients with severely compromised lung function.
about
Risk Factors for Death of Patients with Cystic Fibrosis Awaiting Lung TransplantationDeterminants of mortality for adults with cystic fibrosis admitted in Intensive Care Unit: a multicenter studyChanges in cystic fibrosis airway microbial community associated with a severe decline in lung function.Development of real-time PCR assays for detection of the Streptococcus milleri group from cystic fibrosis clinical specimens by targeting the cpn60 and 16S rRNA genesIndividualised unsupervised exercise training in adults with cystic fibrosis: a 1 year randomised controlled trial.Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007.Growth and lung function in Asian patients with cystic fibrosisReliability and validity of a single item measure of quality of life scale for adult patients with cystic fibrosisPulmonary acceleration time to optimize the timing of lung transplant in cystic fibrosis.Impaired cardiac and peripheral hemodynamic responses to inhaled β₂-agonist in cystic fibrosis.Improving rate of decline of FEV1 in young adults with cystic fibrosis.Cystic fibrosis physicians' perspectives on the timing of referral for lung transplant evaluation: a survey of physicians in the United States.Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.Survival effect of lung transplantation among patients with cystic fibrosisThe role for neutrophil extracellular traps in cystic fibrosis autoimmunity.Nutritional considerations in patients with cystic fibrosis.Does current reporting of lung function by the UK cystic fibrosis registry allow a fair comparison of adult centres?Heterogeneity in Survival in Adult Patients With Cystic Fibrosis With FEV1 < 30% of Predicted in the United States.Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients.An elevated breathing reserve index at the lactate threshold is a predictor of mortality in patients with cystic fibrosis awaiting lung transplantation.Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis.Physiological markers of exercise capacity and lung disease severity in cystic fibrosis.Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis.One-year outcome after severe pulmonary exacerbation in adults with cystic fibrosis.Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality.Changes in pulmonary mechanics with increasing disease severity in children and young adults with cystic fibrosis.Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study.Chest computed tomography scores are predictive of survival in patients with cystic fibrosis awaiting lung transplantation.
P2860
Q22306317-1300B565-1983-4BE7-9491-F8D3D44DB515Q25257344-16A73798-6F42-4F36-92C2-E28A5DCB8C62Q30388877-5E48D5D1-AC2D-4C3B-A43A-D1BBD6ED606FQ33769617-D19EF5B3-D3F0-4BB1-9BD7-25F86D182255Q33983327-49D68175-E3FA-4B47-80D8-54DB3CA2045DQ34610291-F427425D-6F59-4995-BDC6-D33B36A22B0CQ35281189-D39E9D60-D0CD-4E86-A72D-E986DF7CF089Q35605356-CDBA16BC-DF18-437C-975C-4E28DB717F62Q35929774-BE16A411-38BB-4BE8-83B1-2093F4D9C3C8Q36030535-9C7C5BB6-BA27-480E-B248-2998512C36CCQ36183881-497C176E-828B-4F7A-AD4C-1000E2FF8D52Q36254493-6CD7C571-3DED-4045-94B4-96C65D610F28Q36658777-A5914A02-FD75-4F69-8D87-608BD0B1EF4DQ36848757-FB649D6D-FD71-4C6E-88D5-B58D46B85CA5Q37351609-893050BB-D010-4586-9661-B84F52759AD3Q37729993-1F578450-2EC0-4EB9-B97C-A6C967BB89E3Q38809559-FC6FC9EF-F1D7-47B5-B86E-CA864F3C1B2AQ40361294-6E314276-1033-4499-B36F-6A87339FF7EBQ44027842-ACD9CD9F-7983-4F64-A625-9B232764C7F0Q44031736-0C24BC88-3324-41A4-B88D-2853A19E712CQ46453243-F3F9C9FA-0F0E-492E-956B-BFB328C3563FQ47381971-61CC13C0-0492-47A6-9307-605C51244680Q47899170-D2A29FBF-4FA3-45B7-A020-2425826E7DA0Q47907441-DC23042D-714A-4495-ADE7-7339FF80606EQ51699145-BD4742FE-653C-4EBB-87AC-BDD2D1177A7FQ51712229-B3C19D7A-F1F3-4B02-BB5C-79BFB25B1D0CQ53139077-C33A3578-A042-4D81-897D-1B0B2DCD663DQ53171875-1E570C60-F129-4CC1-B1D6-5CC1F5599144
P2860
Risk of death in cystic fibrosis patients with severely compromised lung function.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Risk of death in cystic fibrosis patients with severely compromised lung function.
@en
Risk of death in cystic fibrosis patients with severely compromised lung function.
@nl
type
label
Risk of death in cystic fibrosis patients with severely compromised lung function.
@en
Risk of death in cystic fibrosis patients with severely compromised lung function.
@nl
prefLabel
Risk of death in cystic fibrosis patients with severely compromised lung function.
@en
Risk of death in cystic fibrosis patients with severely compromised lung function.
@nl
P356
P1433
P1476
Risk of death in cystic fibrosis patients with severely compromised lung function.
@en
P2093
P304
P356
10.1378/CHEST.113.5.1230
P407
P577
1998-05-01T00:00:00Z